| Helping to Protect Your Baby by Using RotaTeq® |
| An important reason to vaccinate is to help protect your baby against a severe case of rotavirus. In a large clinical trial, infants who were vaccinated with RotaTeq® were 94% less likely to visit an emergency room and 96% less likely to be hospitalized through the first 2 years after the third dose, due to the types of rotavirus targeted by the vaccine. |
| Who Should Be Vaccinated |
| Your doctor or healthcare professional can give the first dose of RotaTeq® to your baby starting as early as 6 weeks of age. |
| How RotaTeq® Is Given |
| • |
Your child will receive 3 doses of the vaccine. The first dose of RotaTeq® should be administered at 6 to 12 weeks of age and the following doses should be given at an interval of 4 to 10 weeks between each dose. The last (third) dose should be given to your child by 32 weeks of age.
 |
| RotaTeq®—Extensively Tested |
RotaTeq® is available to help protect your child against rotavirus infection.
> Learn more about the effectiveness of RotaTeq®. |
|
|
|
|
| Important Safety Information |
As with other vaccines, RotaTeq® may not fully protect all those who get it. RotaTeq® helps prevent, but does not treat, rotavirus gastroenteritis. Allergic reactions may occur. It should not be given to children who are allergic to any ingredients of the vaccine. Like all vaccines, RotaTeq® may have side effects. The side effects of RotaTeq® are usually mild and do not last long. Side effects reported were diarrhea, vomiting, fever, runny nose and sore throat, wheezing or coughing and ear infection. Other reported side effects include hives. These are not all the possible side effects of RotaTeq®. Before your baby gets RotaTeq®, talk to your physician or pharmacist if he or she has any illness with fever; has diarrhea or is vomiting; has not been gaining weight; is not growing as expected; has a blood disorder; has any type of cancer; has an immune system that is weakened (this includes HIV infection or AIDS); gets treatment or takes medicines that may weaken the immune system; was born with gastrointestinal problems or has had an intestinal blockage; has regular close contact with a member of the family who has a weakened immune system.
Please read the Patient Product Information and discuss it with your doctor or healthcare professional. Also available is the physician Prescribing Information.
|
|
This site is intended for residents of Canada.
® Registered Trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Used under license.
08-11-RTQ-10-CDN-84120523-WEB |
|
|
